Your browser doesn't support javascript.
loading
Real-life data regarding acute procedural success and 1-year clinical outcome of desolve bioresorbable scaffolds.
Gunes, Haci Murat; Gokdeniz, Tayyar; Kizilirmak Yilmaz, Filiz; Demir, Gultekin Gunhan; Guler, Ekrem; Babur Guler, Gamze; Karaca, Oguz; Cakal, Beytullah; Omaygenç, Mehmet Onur; Ibisoglu, Ersin; Boztosun, Bilal.
Afiliación
  • Gunes HM; Faculty of Medicine, Cardiology Department, Medipol University, Istanbul, Turkey.
  • Gokdeniz T; Faculty of Medicine, Cardiology Department, Medipol University, Istanbul, Turkey.
  • Kizilirmak Yilmaz F; Faculty of Medicine, Cardiology Department, Medipol University, Istanbul, Turkey.
  • Demir GG; Faculty of Medicine, Cardiology Department, Medipol University, Istanbul, Turkey.
  • Guler E; Faculty of Medicine, Cardiology Department, Medipol University, Istanbul, Turkey.
  • Babur Guler G; Faculty of Medicine, Cardiology Department, Medipol University, Istanbul, Turkey.
  • Karaca O; Faculty of Medicine, Cardiology Department, Medipol University, Istanbul, Turkey.
  • Cakal B; Faculty of Medicine, Cardiology Department, Medipol University, Istanbul, Turkey.
  • Omaygenç MO; Faculty of Medicine, Cardiology Department, Medipol University, Istanbul, Turkey.
  • Ibisoglu E; Faculty of Medicine, Cardiology Department, Medipol University, Istanbul, Turkey.
  • Boztosun B; Faculty of Medicine, Cardiology Department, Medipol University, Istanbul, Turkey.
J Interv Cardiol ; 30(3): 189-194, 2017 Jun.
Article en En | MEDLINE | ID: mdl-28440067
OBJECTIVES: We aimed to evaluate the peri-procedural success of DESolve bio-resorbable scaffolds (BRSs) and analyzed real-life data about major cardiac events during 1-year follow-up. BACKGROUND: There is little information about real-life data of DESolve BRS which is a novel stent technology offering various advantages over drug eluting stents and commonly used in daily cardiology practice. METHODS: We conducted this single-center and non-randomized cross-sectional study from June 2015 through August 2016 in Medipol University Department of Cardiology and included 117 patients undergoing single or multivessel percutaneous coronary interventions (PCI) with novolimus-eluting BRS devices (152 scaffolds) (Elixir Medical Corporation). Study end points were acute device and procedural success, scaffold thrombosis and major adverse cardiac event (MACE) rates of DESolve BRS. RESULTS: Device success was 96.7% and procedural success was 99.3%. We detected MACE rate as 0.9% while clinical-driven target lesion revascularization was performed in one patient. None of the patients experienced scaffold thrombosis or death. Peri-procedural complications were reported in three patients. CONCLUSIONS: High rates of successful scaffold implantations, low rates of peri-procedural complications, and major cardiac events in long-term suggest that DESolve scaffolds can safely and effectively be used in daily intervention practice by particularly experienced operators.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Complicaciones Posoperatorias / Enfermedad de la Arteria Coronaria / Macrólidos / Implantes Absorbibles / Andamios del Tejido / Stents Liberadores de Fármacos / Intervención Coronaria Percutánea Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Interv Cardiol Asunto de la revista: CARDIOLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Complicaciones Posoperatorias / Enfermedad de la Arteria Coronaria / Macrólidos / Implantes Absorbibles / Andamios del Tejido / Stents Liberadores de Fármacos / Intervención Coronaria Percutánea Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Interv Cardiol Asunto de la revista: CARDIOLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Estados Unidos